Avicenna AI has announced they will partner with Canon Medical Systems to deliver a fully integrated stroke detection artificial intelligence (AI) solution.
Avicenna AI specialises in medical imaging AI, and has produced a programme, Cina Head triage AI solution for neurovascular emergencies, which has been approved by the US Food and Drug Administration (FDA). Cina Head uses a combination of deep learning and machine learning technology to detect and prioritise intracranial haemorrhage (ICH) and large vessel occlusion (LVO).
Cina Head ICH was validated with data from 814 cases, from over 250 imaging centres across the USA, with 96% accuracy, 91.4% sensitivity, and 97.5% specificity. The product’s LVO detection capability was validated based on 476 cases, with 97.7% accuracy, 97.9% sensitivity, and 97.6% specificity. This means that Cina Head is able to detect and prioritise LVO and ICH cases within 20 second, and alerting radiologists to their workflow.
Avicenna will provide Canon with Cina Head, which will be combined with Canon’s automated platform.